Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2552053 | Life Sciences | 2010 | 7 Pages |
Abstract
These results demonstrate that nalmefene is similar to naloxone and naltrexone with respect to its in vivo pharmacology in mice. Specifically, nalmefene produces potent antagonism of morphine agonist effects while precipitating severe withdrawal. The compound has a slower onset and longer duration of action compared to naloxone and naltrexone. The data allows for a more complete preclinical comparison of nalmefene against other opioid antagonists including the putative opioid neutral antagonist 6β-naltrexol.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Melissa D. Osborn, John J. Lowery, Alex G.J. Skorput, Denise Giuvelis, Edward J. Bilsky,